Emily
Editor, Senior Moderator
https://www.nationalheraldindia.com...immunity-antibody-drug-treatment-for-covid-19
UK scientists begin trial of instant immunity antibody drug treatment for COVID-19
The study, led by UCLH virologist Dr Catherine Houlihan, recruited the first participant in the world to the study earlier this month and has recruited 10 participants since then
PTI
Published: 26 Dec 2020, 5:07 PM
Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19.
The University College London Hospitals NHS Trust (UCLH) said that the researchers in the Storm Chase study believe a Long Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to the SARS-CoV-2 coronavirus and prevent them developing COVID-19.
...
We will be recruiting people who are older or in long-term care, and who have conditions such as cancer and HIV which may affect the ability of their immune system to respond to a vaccine.
We want to reassure anyone for whom a vaccine may not work that we can offer an alternative which is just as protective, said Dr Nicky Longley, UCLH infectious diseases consultant leading the Provent study...
UK scientists begin trial of instant immunity antibody drug treatment for COVID-19
The study, led by UCLH virologist Dr Catherine Houlihan, recruited the first participant in the world to the study earlier this month and has recruited 10 participants since then
PTI
Published: 26 Dec 2020, 5:07 PM
Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19.
The University College London Hospitals NHS Trust (UCLH) said that the researchers in the Storm Chase study believe a Long Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to the SARS-CoV-2 coronavirus and prevent them developing COVID-19.
...
We will be recruiting people who are older or in long-term care, and who have conditions such as cancer and HIV which may affect the ability of their immune system to respond to a vaccine.
We want to reassure anyone for whom a vaccine may not work that we can offer an alternative which is just as protective, said Dr Nicky Longley, UCLH infectious diseases consultant leading the Provent study...
